0000927066-24-000025.txt : 20240223 0000927066-24-000025.hdr.sgml : 20240223 20240223174401 ACCESSION NUMBER: 0000927066-24-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240221 FILED AS OF DATE: 20240223 DATE AS OF CHANGE: 20240223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Waters Kathleen Alyce CENTRAL INDEX KEY: 0001640409 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 24672874 MAIL ADDRESS: STREET 1: C/O DAVITA INC. STREET 2: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 4 1 wk-form4_1708728222.xml FORM 4 X0508 4 2024-02-21 0 0000927066 DAVITA INC. DVA 0001640409 Waters Kathleen Alyce C/O DAVITA INC. 2000 16TH STREET DENVER CO 80202 0 1 0 0 Chief Legal & Pub. Affairs Off 0 Common Stock 2024-02-21 4 M 0 40000 52.41 A 121297 D Common Stock 2024-02-21 4 D 0 17044 123 D 104253 D Common Stock 2024-02-21 4 F 0 11671 123 D 92582 D Common Stock 2024-02-21 4 S 0 11285 120.73 D 81297 D Stock Appreciation Rights 52.41 2024-02-21 4 M 0 40000 0 D 2022-06-20 2024-06-20 Common Stock 40000 0 D Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Represents the weighted average sale price of $120.73. The range of prices for the sale of these shares was $120.09 - $122.02 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. The Stock Appreciation Rights were granted on June 20, 2019, which vested 50% each on June 20, 2022 and June 20, 2023. /s/ Stephanie N. Berberich, Attorney-in-Fact 2024-02-23